As for benefits, the first would be a better and clearer understanding of genetic mechanisms, normal and abnormal. In turn, the value for medicine (i.e., for you and me) would be the essential fundamental information gained about the most prominent killers-all of which have a genetic component and which have become the most prominent since the conquest and control of infectious and parasitic disease. They include:
#{149} cancer, which basically is a genetic disease of somatic cells; more would be learned at a basic level about oncogenes, growth factors, processes of differentiation #{149} birth defects such as trisomies 21 (Down's syndrome), 18, and 13-earlier diagnosis, for one thing #{149} heart disease, to which hybrid liposomesand familial hypertension contribute #{149} diabetes, Types I and H #{149} Alzheimer's disease, about 50% of which is probably a genetic disorder, and certain other aging-induced debilities #{149} mental disease such as schizophrenia, alcoholism, and depression, about which almost nothing is certainly known with respect to fundamental etiology #{149} the arthritic diseases These in addition to the less common disorders of genetic origin such as multiple sclerosis, Huntingdon's chorea, 1 See also C&E News, June 16, 1986, p. 4. cystic fibrosis, and Tay-Sachs disease. Moreover, "the question of whether new mutations are produced in the human population by radiation or chemical mutagens will be answered in detail."
There was much concern that funding be sought in such a way that the public (i.e., the taxpayer) will understand what is being undertaken and why;2 that these funds be both federal (but independent of current biomedical research funding rather than competing with its) and from such Midas-rich foundations as the Howard Hughes Medical Institute and from sources outside the United States as well as inside, i.e., that this be a worldwide effort; and that current workers in the field not be made to feel that their enterprise is being usurped.
The public should also be made aware that this is not a brand-new project but in fact an ongoing one, with several parts already organized and (or) running, in what passes for Big Sciencein molecular biology-such as GENBANK, the National Laboratory Human Gene Library project, the closely related Human Protein Index, and DNA databases at the European Molecular Biology Laboratory.
There was agreement that sucjl a project should have a tight-control administrative/monitoring body. There was less agreement, not surprisingly, on how best to set about the task, whether the work would most efficiently be done in a single dedicated centralized laboratory or (at the other end of the spectrum of opinion) on a cottage-industry basis, with x-number of academic and industrial research laboratories participating cooperatively in performing those specific segments of the task that best fit their interests and capabilities.
The clear consensus was that now is the time to begin detailed planning and actually to make a start on such a project.
The politicalisocial obstacles match the technical/scientific areas.
There is going to be opposition to this project from administrators of organizations that necessarily must chip away at specific diseases rather than attack them at the roots. The March of Dimes, for example, is unlikely to double-quick-march in its support. Nor are the proponents of (e.g.) superconducting supercolliders, unmanned launch vehicles (which have been blowing up lately with tiresome regularity, at a cost of tens of millions per blast),4 or Star Wars (SDI) going to be enthusiasts for this project. Rather, in the words of a participant, if the proposalis to stand a chance of going forward in the way envisioned, one must "demonstrate to each citizen thatthe project is feasible and that his own future health and part of his economic well-2A formidable test in itself when most ofthe public is innocent of any knowledge of genetics. 3An even more formidable task currently, in view of GrammRudman-Hollings et al.
4For perspective,developmentcosts alonefor the shuttle were on the order of $5 billion.
CLINICALCHEMISTRY, Vol. 32, No. 8, 1986 1601 being depend on the project." Public support is an essential and potent ingredient here. Once this is gained, we know that presidents love to put their prestige behind projects that are popular and that they hope or imagine will leave them beloved in history: the New Deal, the New Frontier, the Great Society, and Battle against Cancer, and now, Star Wars.
I for one5am willing temporarily to forego some of my alleged national defense, some further information on the building blocks of matter, and plans for colonizing Mars, all 6This is a personal, not an officialAssociation view, of course.
in favor of a Big Scienceproject in biology for which the time is ripe and which holds a readily and regularly assessable high probability of benefit to every person on the planet. George Kenworth (Director, Office of Science and Technology, The White House) has suggested that biotechnology is the most important high-tech for the future of the United States. Will politics allow plans to be put into action? "It is difficult to conceive of any single advance in biomedical science that will have as great an impact as this on the development of new understanding of all disease and the devising of new measures to diagnose, treat, and prevent many human afflictions" (T.T. Puck).
-J S. King
